论文部分内容阅读
目的:探索安多霖联合氟他胺治疗前列腺癌的应用价值。方法:对13例前列腺癌患者口服氟他胺加用安多霖治疗。分别测定血清PSA。结果:3例PSA≤4 ng/ml,7例PSA下降值超过50%,7例伴有骨转移灶疼痛大部分症状得到缓解。11例尿频、排尿不尽感改善。没有明显不良反应。结论:安多霖联合氟他胺治疗其疗效肯定,不良反应小,可作为前列腺癌的一种辅助治疗。
Objective: To explore the application of Androlol combined with flutamide in the treatment of prostate cancer. Methods: Thirteen patients with prostate cancer were treated with oral flutamide plus Andoriding. Serum PSA was measured separately. Results: PSA was lower than 4 ng / ml in 3 cases, PSA in 7 cases was decreased by more than 50%, and most of the symptoms of 7 patients with bone metastases were relieved. Eleven cases of frequent urination, urination improved. No obvious adverse reactions. Conclusion: Andolin combined with flutamide treatment of its positive effect, small adverse reactions, can be used as an adjuvant treatment of prostate cancer.